Thromboresistant surface treatment for biomaterials
First Claim
1. A biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomedical is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
1 Assignment
0 Petitions
Accused Products
Abstract
A biomaterial with a thromboresistant surface and a method for forming same are provided. The thromboresistant surface is comprised of a distinct coating layer of a chitosan-based membrane and a biologically active material. The biologically active material is capable of converting the chitosan membrane coating from a highly thrombogenic to an essentially non-thrombogenic one. The biologically active material can be a polymeric substance, such as polyvinyl alcohol, forming a polymeric blend with the chitosan, or, can be a biological substance, such as serum albumin, embedded in or attached to the chitosan membrane which has been activated with a treatment of glutardialdehyde. The thromboresistant biomaterial is suitable for use in vascular grafts having an inside diameter of less than 6 millimeters.
499 Citations
17 Claims
- 1. A biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomedical is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
- 5. A biomaterial which has improved antithrombogenic properties and improved strength, which biomaterial has a coating which comprises a blend of chitosan and polyvinyl alcohol wherein the biomaterial is a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals, which biomaterial is for use in a device or prosthesis having a blood contacting surface.
- 7. A biomaterial which has improved antithrombogenic properties and which has a coating which comprises chitosan and as a biologically active material which active material is attached to the chitosan at glutaraldehyde-activated free amino sites, human serum albumin.
- 9. A process for treating a biomaterial for use in a biomedical device or prosthesis which has a blood contacting surface, which has improved antithrombogenic properties and improved strength, comprising contacting the surface of the biomaterial with a mixture of a solution of chitosan and polyvinyl alcohol, removing any excess solution, and curing the remaining solution on the surface, thereby obtaining the improved coating, the biomaterial being a homopolymer or a copolymer selected from the group consisting of polytetrafluoroethylenes, polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals.
- 11. A process for treating a biomaterial for use in a biomedical device or prosthesis which has a blood contacting surface and improved antithrombotic properties, comprising contacting the surface of the biomaterial with a chitosan solution, and activating free amino groups on the chitosan by treating the chitosan on the surface of the biomaterial with a solution of glutaraldehyde, wherein the biomaterial is a homopolymer or a copolymer selected from the group consisting of polyamides, polyesters, polyurethanes, polysiloxanes, polyolefins, silicone rubber, polyvinyl chlorides, and metals and treating the activated chitosan with a biologically active material selected from the group consisting of surfactants, antithrombotic agents, antibiotics, and antibodies.
- 14. A polymeric or metal biomedical device or prosthesis having a blood contacting surface which has improved antithrombogenic properties and improved strength, which device or prosthesis has a coating which comprises a blend of chitosan and polyvinyl alcohol, wherein the device or prosthesis has a portion which is tubular of an interior diameter of less than 6 mm.
Specification